Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 25-hydroxyvitamin D to preparation of evaluation kit for disease activity of patient suffering from aorto-arteritis

A technology for hydroxyvitamin and Takayasu arteritis is applied in the field of preparing a disease activity evaluation kit for patients with Takayasu arteritis, which can solve the problems of inability to meet the clinical needs of accurately evaluating disease activity and the like

Active Publication Date: 2018-09-11
北京豪思生物科技股份有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, it cannot meet the clinical needs of accurately judging disease activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 25-hydroxyvitamin D to preparation of evaluation kit for disease activity of patient suffering from aorto-arteritis
  • Application of 25-hydroxyvitamin D to preparation of evaluation kit for disease activity of patient suffering from aorto-arteritis
  • Application of 25-hydroxyvitamin D to preparation of evaluation kit for disease activity of patient suffering from aorto-arteritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] By detecting the concentration of 25(OH)D in the plasma of 126 patients with Takayasu arteritis and 154 healthy control subjects, the mean value of 25(OH)D in the plasma of 154 healthy control groups was 19.63ng / ml (range: 8.79 to 36.64ng / m1), and the level of plasma 25(OH)D in patients with Takayasu arteritis was significantly lower than that in healthy controls (p<0.01), and the average value was 16.29 (the numerical value here is to include active Takayasu arteritis patients and latent period Mean values ​​obtained from patients with Takayasu arteritis) ng / ml (range: 5.2 to 39.40 ng / m1).

[0053] When patients with Takayasu arteritis were divided into active phase and latent phase according to disease activity, the mean value of plasma 25(OH)D in active phase patients was 13.29 ng / ml (range: 5.2 to 30.05 ng / m1), while in The average value of patients in the incubation period was 21.25ng / ml (range: 14.92 to 39.40ng / m1), and the results of statistical analysis showed t...

Embodiment 2

[0060] In the treatment of patients with Takayasu arteritis, commonly used drugs are glucocorticoids and immunosuppressants. Hormone is still the main treatment drug for patients with active disease, but hormone therapy can cause adverse reactions such as osteoporosis, so patients using hormone therapy will be given vitamin D supplementation. So does vitamin D supplementation affect the association between 25(OH)D and disease activity? The present study found that vitamin D supplementation or no supplementation did not affect the correlation between 25(OH)D and disease activity. Such as figure 2 It was shown that whether the patients with Takayasu arteritis were supplemented with vitamin D or not, when the disease activity turned into the latent stage, the plasma 25(OH)D level rose to a cutoff value of 15.98ng / ml or more. When the active state of the disease turned to active, the 25(OH)D level decreased to below the cutoff value of 15.98ng / ml.

[0061] During the treatment...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of 25-hydroxyvitamin D to preparation of an evaluation and / or aided evaluation kit for the disease activity of a patient suffering from aorto-arteritis and furtherdiscloses the evaluation and / or aided evaluation kit for the disease activity of the patient suffering from aorto-arteritis. The kit comprises a product for detecting the content of 25-hydroxyvitaminD in a biological sample of the patient suffering from aorto-arteritis and further comprises a carrier on which the following judgment standards are recorded: when the concentration of the 25-hydroxyvitamin D in the biological sample is lower than 15.98ng / ml, the patient is determined to be in an active stage of aorto-arteritis, and when the concentration of the 25-hydroxyvitamin D in the biological sample is equal to or higher than 15.98ng / ml, the patient is determined to be in an incubation period of aorto-arteritis.

Description

technical field [0001] The invention relates to the application of 25-hydroxyvitamin D in the preparation of a disease activity evaluation kit for patients with Takayasu arteritis. Background technique [0002] At present, there are no good serological indicators for judging disease activity in patients with Takayasu arteritis, except for imaging data. [0003] The etiology of Takayasu arteritis is still unclear. Pathological studies have shown that mononuclear cells (CD4+ and CD8+ T cells, plasma cells and macrophages) infiltrate the vessel wall of patients with Takayasu arteritis. Play an important role in the pathogenesis process. CD4 and CD8 lymphocytes, natural killer cells and macrophages infiltrate the three layers of blood vessel walls by releasing inflammatory factors TNF-a, INF-γ, IL-6 and IL-17 as well as vascular endothelial growth factor (VEGF) and platelet growth factor Factors such as PDGF promote intima proliferation, thickening of blood vessel walls, or da...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06G01N2030/027G01N2030/062
Inventor 杜杰王媛李凤娟檀鑫王雪
Owner 北京豪思生物科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com